This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mehta J, Powles R, Sirohi B et al. Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant 2002 29: 853 859
Mielcarek M, Leisenring W, Torok-Storb B et al. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Blood 2000 96: 1150 1156
Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens Blood 1990 76: 1867 1871
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mehta, J. Response to Mielcarek et al. Bone Marrow Transplant 30, 548 (2002). https://doi.org/10.1038/sj.bmt.1703707
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703707